CBD Market

UK CBD brand TRIP raises $12m to support global growth

The latest round of funding will support the brand’s continued growth in the United States and across the globe.

UK CBD brand TRIP raises $12m to support global growth
Home / UK CBD brand TRIP raises $12m to support global growth

TRIP has raised $12m (~£10.17m) investment supported by prominent entrepreneurs, business leaders and investors, including Maria Raga, the former CEO of Depop and Christian Angermayer, founder of Apeiron Investment Group.

The CBD wellbeing category is continuing its steady upward trajectory. With TRIP quickly becoming a global leader in the space, the company’s latest raise will continue to drive its growth and deepen its US distribution. 

Known in the UK as the “Queen’s CBD,” having received the royal seal of approval by selling out of the Queen’s Windsor shop, TRIP was founded by husband-and-wife team Daniel Khoury and Olivia Ferdi after meeting at Cambridge University. 

Read more: Successful £2m fundraise completed by Love Hemp

The duo launched TRIP after a transformational personal experience with CBD when it helped Daniel recover from an accident that required knee surgery just before their wedding. Amazed by CBD’s benefits, the two left their careers in law and finance to launch TRIP together and designed an award-winning range of drinks, oils and gummies to help people find calm.

TRIP co-founder Olivia Ferdi commented: “Over the last few years the world’s attitude towards the importance of mental health has changed dramatically. 

“Since discovering the power of CBD through an incredible personal experience, our mission has always been to share calm in the everyday chaos, with next-generation wellbeing products to power your lifestyle and help care for your mental health. 

“Helping to open up conversations around stress and anxiety, we’re excited to create a community across the globe, harnessing the power of plants to find their calm.”

TRIP has now set its sights on the global wellbeing landscape, expanding its retail footprint through strategic partnerships in the United States as Soho House & Co.’s exclusive global CBD supplier and in Los Angeles-based retailer Erewhon.

“TRIP is a Soho House favourite,” said Soho House & Co. drinking director Tom Kerr. “After assessing CBD brands globally we knew TRIP was the perfect partner brand for Soho House. Since launch, they’ve been a huge hit in our houses around the world.”

[activecampaign form=31]

Topicscannabis industryCBD industryCBD products

Stephanie Price

Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".

More from Stephanie

Spotted an error, or have a tip? Contact the newsroom.